Posttraumatic stress disorder in pediatric patients with implantable cardioverter-defibrillators and their parents.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
09 2022
Historique:
received: 06 12 2021
revised: 13 06 2022
accepted: 22 06 2022
pubmed: 1 7 2022
medline: 9 9 2022
entrez: 30 6 2022
Statut: ppublish

Résumé

An implantable cardioverter-defibrillator (ICD) in the pediatric patient (and the precipitating events that led to ICD placement) can be traumatic for patients and their families and may lead to posttraumatic stress disorder (PTSD). This study aimed to estimate the prevalence of PTSD in pediatric patients with an ICD and their parents and identify the factors associated with PTSD incidence. Pediatric participants with an ICD aged 8-21 years and parents of children aged 0-21 years completed surveys that included demographic characteristics and PTSD measures. Pediatric participants completed additional psychosocial measures, such as anxiety and depression self-report questionnaires. Fifty youth (30% female) and 43 parents (70% female) completed the measures. Six of 50 youth (12%) met the screening criteria for a likely PTSD diagnosis, while 20 of 43 parents (47%) met the cutoff for PTSD on the screening measure. Children with PTSD were more likely to have had a secondary prevention ICD (83% vs 17%; P = .021), meet the clinical cutoff for depression (67% vs 16%; P = .005), and had higher shock anxiety scores (31.7 vs 17.9; P = .003) than children without PTSD. Female gender (57% vs 23%; P = .043) and patient depression (31% vs 5%; P = .042) were associated with PTSD in parents. Parents were found to be more likely to meet the criteria for PTSD than youth. In youth, PTSD was associated with medical and psychosocial factors, whereas PTSD in parents was associated with being female and child depression. Clinic-based screenings and management planning of emotional functioning are warranted to address psychological distress in patients and parents.

Sections du résumé

BACKGROUND
An implantable cardioverter-defibrillator (ICD) in the pediatric patient (and the precipitating events that led to ICD placement) can be traumatic for patients and their families and may lead to posttraumatic stress disorder (PTSD).
OBJECTIVES
This study aimed to estimate the prevalence of PTSD in pediatric patients with an ICD and their parents and identify the factors associated with PTSD incidence.
METHODS
Pediatric participants with an ICD aged 8-21 years and parents of children aged 0-21 years completed surveys that included demographic characteristics and PTSD measures. Pediatric participants completed additional psychosocial measures, such as anxiety and depression self-report questionnaires.
RESULTS
Fifty youth (30% female) and 43 parents (70% female) completed the measures. Six of 50 youth (12%) met the screening criteria for a likely PTSD diagnosis, while 20 of 43 parents (47%) met the cutoff for PTSD on the screening measure. Children with PTSD were more likely to have had a secondary prevention ICD (83% vs 17%; P = .021), meet the clinical cutoff for depression (67% vs 16%; P = .005), and had higher shock anxiety scores (31.7 vs 17.9; P = .003) than children without PTSD. Female gender (57% vs 23%; P = .043) and patient depression (31% vs 5%; P = .042) were associated with PTSD in parents.
CONCLUSION
Parents were found to be more likely to meet the criteria for PTSD than youth. In youth, PTSD was associated with medical and psychosocial factors, whereas PTSD in parents was associated with being female and child depression. Clinic-based screenings and management planning of emotional functioning are warranted to address psychological distress in patients and parents.

Identifiants

pubmed: 35772698
pii: S1547-5271(22)02154-3
doi: 10.1016/j.hrthm.2022.06.025
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1524-1529

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Lauren M Schneider (LM)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California. Electronic address: lmikula@stanford.edu.

Jessie J Wong (JJ)

Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

Rebecca Adams (R)

Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

Brady Bates (B)

Valley Children's Healthcare, Madera, California.

Spenser Chen (S)

Lucile Packard Children's Hospital at Stanford, Palo Alto, California.

Scott R Ceresnak (SR)

Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

Michael Danovsky (M)

Valley Children's Healthcare, Madera, California.

Debra Hanisch (D)

Lucile Packard Children's Hospital at Stanford, Palo Alto, California.

Kara S Motonaga (KS)

Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

Miguel Restrepo (M)

Valley Children's Healthcare, Madera, California.

Richard J Shaw (RJ)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.

Samuel F Sears (SF)

Department of Psychology and Cardiovascular Science, East Carolina University, Greenville, North California.

Anthony Trela (A)

Lucile Packard Children's Hospital at Stanford, Palo Alto, California.

Anne M Dubin (AM)

Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

Korey K Hood (KK)

Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH